Synthetic biology firm Geneart in the ascendency
Germany's Geneart, a specialist in synthetic biology, is expecting strong growth in 2008 on the back of strong demand for gene synthesis.
Archives for February 12, 2008
DNA extraction for all, says Mole Genetics
Mole Genetics has launched its low cost, benchtop personal DNA extraction/purification system to the European market.
Beckman Coulter sees earnings drop in Q4
Beckman Coulter saw its fourth quarter earnings held back by the cost of acquiring NexGen Diagnostics, but the underlying business was strong with a near-11 per cent hike in revenues.
Four Indian vaccine makers have license suspended after failing GMP
Four of India's biggest vaccine manufacturers have had their licenses suspended by the Indian government after failing to meet good manufacturing practise (GMP) requirements, according to local media reports.
Green tea extract's Janus Effect on stomach health: study
The green tea polyphenol (-)-epicatechin-3-gallate (ECG) may slash the risk of gastric cancer among women by 75 per cent, suggests a new study from Japan.
Microneedles could expand transdermal delivery of drugs
A new study has demonstrated for the first that microneedle technology is able to overcome some of the barriers preventing the transdermal administration of drugs with low bioavailability.
Invitrogen and Agilent settle differences
After several years, Invitrogen and Agilent have at last settled patent infringement court cases concerning tools used in complementary DNA synthesis, polymerase chain reaction (PCR) and other molecular biology applications.